Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT Pilot: Dalteparin vs UFH for VTE Prophylaxis in ICU
NCT00182364Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Feb 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of dalteparin in deep vein thrombosis (DVT), pulmonary embolism (PE), sponsored by Hamilton Health Sciences. Started Feb 2003; status: completed.
02
Drugs
dalteparin
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00182364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182364.